1 coupled with accelerated growth permitted by iron compounds.

2 amounts of oxidants and low-molecular-weight iron compounds.

3 is may acquire iron from iron salts and host iron compounds.

4 ity of the dioxo dianion and the hydroperoxo-iron (compound 0) intermediates in the catalytic cycle a

5           Cells treated with a lipid soluble iron compound 3,5, 5-trimethyl (hexanoyl) ferrocene (TMH

6 absorption, particularly from poorly soluble iron compounds and in combination with phytase.The objec

7           Reducing the particle size of some iron compounds can improve their bioavailability in rats

8         The presence of low molecular weight iron compounds can stimulate free radical production in

9 e to locally identify the oxidation state of iron compounds encrusting the 5 to 10 mum microfossils.

10 react with alcohol to give monohydride amine iron compounds FeH(OR')(CO)(P-CH2NH-P'), R' = Me, CMe2Et

11              Although bacteria use different iron compounds in vitGro, the possibility that microbes

12                           A seventh putative iron compound receptor, encoded by CFT073 open reading f

13 3 outer membrane antigens, including a novel iron compound receptor, reacted with the antisera and we

14                               Similar to the iron compound, several other transition-metal carbodiimi

15 iple mutant is able to directly pirate plant iron compounds such as heme/hemin or iron-nicotianamine,

16                                       Of the iron compounds tested, TMH-ferrocene most accurately sim

17  and computational studies established S = 1 iron compounds that are best described as intermediate-s

18 he astrocytes were exposed to the lipophilic iron compound TMH-ferrocene and t-bOOH.

19 eactions between selected substrates and the iron compound under a N(2) atmosphere established transf

20 ing growth in urine; six known receptors for iron compounds were induced in this environment, i.e., C